Key Policy Change that will accelerate the Indian CDMO Story Further!
The Biosecure Act would prohibit US companies receiving federal grant money from working with four Chinese biotech companies, including WuXi AppTec and its sister company WuXi Biologics, which produce active pharmaceutical ingredients (API) for hundreds of US and European drugmakers.
https://www.ropesgray.com/en/insights/alerts/2024/03/the-biosecure-act-a-review-of-the-bill-responses-and-possible-repercussions
https://twitter.com/soicfinance/status/1778484622348988647
| Subscribe To Our Free Newsletter |
